home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

DNA Damage Limitation

  February, 4 2003 9:27
your information resource in human molecular genetics
ATM, the gene mutated in the hereditary disease ataxiaûtelangiectasia, codes for a protein kinase that acts as a master regulator of cellular responses to DNA double-strand breaks. ATM protein is normally inactive and the question of how it becomes active in the event of DNA damage - due to ionizing radiation, for instance - is central to understanding its function.

In this week's Nature (Vol. 421, No. 6922, 30 January 2003, pp. 499-506), Michael B. Kastan and Christopher J. Bakkenist of the St Jude Children's Research Hospital, Memphis, Tennessee, show that the ATM protein is present in normal undamaged cells as an inactive dimer, with its kinase domain bound to a region surrounding serine residue 1981, part of the 'FAT' (focal adhesion target) domain of the protein.

Low doses of ionizing radiation, which induce only a few DNA strand breaks, activate at least half of the total ATM protein present, possibly through a response to changes in chromatin structure, the researchers report.

In an accompanying News and Views article, Jiri Bartek and Jiri Lukas of the Danish Cancer Society, Copenhagen, Denmark, discuss the background and ramifications of this work.


Michael B. Kastan
tel +1 901 495 3968
e-mail michael.kastan@stjude.org

Jiri Bartek
tel +45 35 25 73 57/75 00
e-mail bartek@biobase.dk

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.